Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: Dietary Salt in Rheumatoid Arthritis [NA]
This clinical trial update confirms the study evaluating dietary salt intake in rheumatoid arthritis has completed and posted its results.
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis: [NA]
A completed clinical trial evaluating cardiovascular risk assessment in patients with rheumatoid arthritis has posted results.
-
EMA approval · 2025-10-22EMA Authorised: Amsparity (adalimumab) — Pfizer Europe MA EEIG
EMA authorised Amsparity (adalimumab) from Pfizer Europe MA EEIG. The biosimilar is approved for multiple autoimmune indications including r…
-
EMA approval · 2025-10-21EMA Authorised: Idacio (adalimumab) — Fresenius Kabi Deutschland GmbH
EMA authorised Idacio, a biosimilar of adalimumab, for multiple inflammatory diseases, produced by Fresenius Kabi Deutschland GmbH. The indi…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: G7 Freedom Constrained Vivacit-E Liners [NA]
Enrollment by invitation is ongoing for the G7 Freedom Constrained Vivacit-E Liners in a hip-related trial; the study targets various hip co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-10-17FDA Approved: HADLIMA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for HADLIMA (adalimumab-bwwd) from Organon LLC, supporting expanded indications for this adalimumab …
-
EMA approval · 2025-10-17EMA Authorised: Arava (leflunomide) — Sanofi-aventis Deutschland GmbH
The European Medicines Agency authorised Arava (leflunomide) for the treatment of rheumatoid arthritis and psoriatic arthritis, with Sanofi-…
-
FDA approval · 2025-10-16FDA Approved: XELJANZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for XELJANZ (tofacitinib) filed by Pfizer Laboratories Div Pfizer Inc, resulting in changes to t…
-
FDA approval · 2025-10-16FDA Approved: AMJEVITA — Supplemental Application (Nuvaila Limited)
FDA approved a supplemental application for Amjevita (adalimumab-atto) submitted by Nuvaila Limited.
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis [Phase 2]
Phase 2 trial evaluating the safety and efficacy of Nipocalimab in combination with Certolizumab Pegol in adults with active rheumatoid arth…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Teleconsultation Approach to CTD-ILD Care Delivery in Rural UnderServed CommuniTies (TRUST Initiative)
This clinical trial update describes the TRUST Initiative, a teleconsultation approach to care for connective tissue disease–associated inte…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity [NA]
This document provides an update on a rheumatology-focused clinical trial sponsored by Brigham and Women's Hospital that studies an adaptive…
-
EMA approval · 2025-10-08EMA Authorised: Humira (adalimumab) — AbbVie Deutschland GmbH & Co. KG
The EMA authorised Humira (adalimumab) by AbbVie Deutschland GmbH & Co. KG for multiple indications including ankylosing spondylitis, juveni…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Comorbidity Management in Rheumatic Disease. [NA]
Update on a clinical trial sponsored by Western University investigating comorbidity management in rheumatoid arthritis. The study is curren…
-
EMA approval · 2025-10-06EMA Authorised: Rixathon (rituximab) — Sandoz GmbH
EMA authorised Rixathon (rituximab) by Sandoz as a biosimilar to Rituxan for several autoimmune and hematologic diseases, expanding access t…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis [Phase 2]
Phase 2 dose-response study evaluating oral AP1189 in DMARD-naïve patients with early rheumatoid arthritis. Recruitment is ongoing.
-
CLINICAL_TRIALS withdrawal · 2025-10-06Clinical Trial Update: The Use of Synovial Biopsies in Predicting Response to Biologic Therapy in Rheumatoid Arthritis Patients [Phase 3]
Phase 3 clinical trial evaluating whether synovial biopsy findings can predict response to biologic therapy in rheumatoid arthritis, which h…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis [Phase 3]
A Phase 3 clinical trial investigating a sequential treatment strategy for rheumatoid arthritis is currently recruiting.
-
FDA approval · 2025-10-03FDA Approved: NAPROXEN — Original Application (Aurobindo Pharma Limited)
FDA approved Naproxen from Aurobindo Pharma Limited as an original generic application (ANDA 216504). Naproxen is a nonsteroidal anti-inflam…
-
EMA approval · 2025-10-02EMA Authorised: Tyenne (tocilizumab) — Fresenius Kabi Deutschland GmbH
EMA authorised Tyenne (tocilizumab) by Fresenius Kabi Deutschland GmbH for multiple indications, including rheumatoid arthritis, juvenile id…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry
This clinical trial update describes the CorEvitas Rheumatoid Arthritis Drug Safety & Effectiveness Registry, a real-world observational stu…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Study of LW402 Tablets in Moderate to Severe Rheumatoid Arthritis [Phase 2]
A Phase 2 study of LW402 tablets for rheumatoid arthritis has completed the trial status and is marked as completed.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: CorEvitas Japan Rheumatoid Arthritis (RA) Registry
An observational registry in Japan for rheumatoid arthritis sponsored by CorEvitas, currently active but not recruiting, to collect real-wor…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: RhEumatoid Arthritis MEDIcation Adherence [NA]
A clinical trial assessing medication adherence for rheumatoid arthritis is currently recruiting, sponsored by Hospices Civils de Lyon.
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: STudying Ageing in Rheumatic Diseases (STAR)
STAR is a clinical trial investigating ageing in rheumatic diseases, focusing on rheumatoid arthritis. The study is currently active but not…